Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2008 1
2009 1
2010 3
2011 4
2012 2
2013 1
2016 1
2019 2
2020 1
2021 2
2022 2
2023 6
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
Differentiating Multiple Sclerosis From AQP4-Neuromyelitis Optica Spectrum Disorder and MOG-Antibody Disease With Imaging.
Cortese R, Prados Carrasco F, Tur C, Bianchi A, Brownlee W, De Angelis F, De La Paz I, Grussu F, Haider L, Jacob A, Kanber B, Magnollay L, Nicholas RS, Trip A, Yiannakas M, Toosy AT, Hacohen Y, Barkhof F, Ciccarelli O. Cortese R, et al. Among authors: bianchi a. Neurology. 2023 Jan 17;100(3):e308-e323. doi: 10.1212/WNL.0000000000201465. Epub 2022 Oct 3. Neurology. 2023. PMID: 36192175 Free PMC article.
Networks of microstructural damage predict disability in multiple sclerosis.
Colato E, Prados F, Stutters J, Bianchi A, Narayanan S, Arnold DL, Wheeler-Kingshott C, Barkhof F, Ciccarelli O, Chard DT, Eshaghi A. Colato E, et al. Among authors: bianchi a. J Neurol Neurosurg Psychiatry. 2023 Dec;94(12):992-1003. doi: 10.1136/jnnp-2022-330203. Epub 2023 Jul 19. J Neurol Neurosurg Psychiatry. 2023. PMID: 37468305
Clinical and MRI measures to identify non-acute MOG-antibody disease in adults.
Cortese R, Battaglini M, Prados F, Bianchi A, Haider L, Jacob A, Palace J, Messina S, Paul F, Wuerfel J, Marignier R, Durand-Dubief F, de Medeiros Rimkus C, Callegaro D, Sato DK, Filippi M, Rocca MA, Cacciaguerra L, Rovira A, Sastre-Garriga J, Arrambide G, Liu Y, Duan Y, Gasperini C, Tortorella C, Ruggieri S, Amato MP, Ulivelli M, Groppa S, Grothe M, Llufriu S, Sepulveda M, Lukas C, Bellenberg B, Schneider R, Sowa P, Celius EG, Proebstel AK, Yaldizli Ö, Müller J, Stankoff B, Bodini B, Carmisciano L, Sormani MP, Barkhof F, De Stefano N, Ciccarelli O; MAGNIMS Study Group. Cortese R, et al. Among authors: bianchi a. Brain. 2023 Jun 1;146(6):2489-2501. doi: 10.1093/brain/awac480. Brain. 2023. PMID: 36515653
Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis.
Landi D, Bovis F, Grimaldi A, Annovazzi PO, Bertolotto A, Bianchi A, Borriello G, Brescia Morra V, Bucello S, Buscarinu MC, Caleri F, Capobianco M, Capra R, Cellerino M, Centonze D, Cerqua R, Chisari CG, Clerico M, Cocco E, Cola G, Cordioli C, Curti E, d'Ambrosio A, D'Amico E, De Luca G, Di Filippo M, Di Lemme S, Fantozzi R, Ferraro D, Ferraro E, Gallo A, Gasperini C, Granella F, Inglese M, Lanzillo R, Lorefice L, Lus G, Malucchi S, Margoni M, Mataluni G, Mirabella M, Moiola L, Nicoletti CG, Nociti V, Patti F, Pinardi F, Portaccio E, Pozzilli C, Ragonese P, Rasia S, Salemi G, Signoriello E, Vitetta F, Totaro R, Sormani MP, Amato MP, Marfia GA. Landi D, et al. Among authors: bianchi a. J Neurol Neurosurg Psychiatry. 2022 Sep 30:jnnp-2022-329657. doi: 10.1136/jnnp-2022-329657. Online ahead of print. J Neurol Neurosurg Psychiatry. 2022. PMID: 36180219
Tocilizumab treatment in MOGAD: a case report and literature review.
Schirò G, Iacono S, Andolina M, Bianchi A, Ragonese P, Salemi G. Schirò G, et al. Among authors: bianchi a. Neurol Sci. 2024 Apr;45(4):1429-1436. doi: 10.1007/s10072-023-07189-7. Epub 2023 Nov 27. Neurol Sci. 2024. PMID: 38010585 Free PMC article. Review.
Cardiovascular risk factors in secondary progressive multiple sclerosis: A cross-sectional analysis from the MS-STAT2 randomized controlled trial.
Williams T, John N, Calvi A, Bianchi A, De Angelis F, Doshi A, Wright S, Shatila M, Yiannakas MC, Chowdhury F, Stutters J, Ricciardi A, Prados F, MacManus D, Braisher M, Blackstone J, Ciccarelli O, Gandini Wheeler-Kingshott CAM, Barkhof F, Chataway J; UCL MS-STAT2 investigators. Williams T, et al. Among authors: bianchi a. Eur J Neurol. 2023 Sep;30(9):2769-2780. doi: 10.1111/ene.15924. Epub 2023 Jun 23. Eur J Neurol. 2023. PMID: 37318885 Clinical Trial.
Optic chiasm involvement in multiple sclerosis, aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein-associated disease.
Bianchi A, Cortese R, Prados F, Tur C, Kanber B, Yiannakas MC, Samson R, De Angelis F, Magnollay L, Jacob A, Brownlee W, Trip A, Nicholas R, Hacohen Y, Barkhof F, Ciccarelli O, Toosy AT. Bianchi A, et al. Mult Scler. 2024 May;30(6):674-686. doi: 10.1177/13524585241240420. Epub 2024 Apr 22. Mult Scler. 2024. PMID: 38646958 Free PMC article.
Real world experience with teriflunomide in multiple sclerosis: the TER-Italy study.
Bucello S, Annovazzi P, Ragonese P, Altieri M, Barcella V, Bergamaschi R, Bianchi A, Borriello G, Buscarinu MC, Callari G, Capobianco M, Capone F, Cavalla P, Cavarretta R, Cortese A, De Luca G, Di Filippo M, Dattola V, Fantozzi R, Ferraro E, Filippi MM, Gasperini C, Grimaldi LME, Landi D, Re ML, Mallucci G, Manganotti P, Marfia GA, Mirabella M, Perini P, Pisa M, Realmuto S, Russo M, Tomassini V, Torri-Clerici VLA, Zaffaroni M, Zuliani C, Zywicki S, Filippi M, Prosperini L. Bucello S, et al. Among authors: bianchi a. J Neurol. 2021 Aug;268(8):2922-2932. doi: 10.1007/s00415-021-10455-3. Epub 2021 Feb 22. J Neurol. 2021. PMID: 33616742
26 results